Sinn HP - Search Results

1

Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapy.

Schouten PC, Marmé F, Aulmann S, Sinn HP, van Essen HF, Ylstra B, Hauptmann M, Schneeweiss A, Linn SC. Schouten PC, et al. Among authors: sinn hp. Clin Cancer Res. 2015 Feb 15;21(4):763-70. doi: 10.1158/1078-0432.CCR-14-1894. Epub 2014 Dec 5. Clin Cancer Res. 2015. PMID: 25480832

2

Survival and tumor characteristics of German hereditary breast cancer patients.

Hamann U, Sinn HP. Hamann U, et al. Among authors: sinn hp. Breast Cancer Res Treat. 2000 Jan;59(2):185-92. doi: 10.1023/a:1006350518190. Breast Cancer Res Treat. 2000. PMID: 10817354

3

Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: sinn hp. Stem Cells. 2002;20(1):32-40. doi: 10.1634/stemcells.20-1-32. Stem Cells. 2002. PMID: 11796920

4

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: sinn hp. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

5

C-myc oncogene amplification in ductal carcinoma in situ of the breast.

Aulmann S, Bentz M, Sinn HP. Aulmann S, et al. Among authors: sinn hp. Breast Cancer Res Treat. 2002 Jul;74(1):25-31. doi: 10.1023/a:1016061327812. Breast Cancer Res Treat. 2002. PMID: 12150449

6

CTCF gene mutations in invasive ductal breast cancer.

Aulmann S, Bläker H, Penzel R, Rieker RJ, Otto HF, Sinn HP. Aulmann S, et al. Among authors: sinn hp. Breast Cancer Res Treat. 2003 Aug;80(3):347-52. doi: 10.1023/A:1024930404629. Breast Cancer Res Treat. 2003. PMID: 14503807

7

Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.

Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U, Ho AD, Bastert G, Krämer A. Schneeweiss A, et al. Among authors: sinn hp. Int J Cancer. 2003 Nov 10;107(3):346-52. doi: 10.1002/ijc.11408. Int J Cancer. 2003. PMID: 14506732

8

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.

Schneeweiss A, Katretchko J, Sinn HP, Unnebrink K, Rudlowski C, Geberth M, Beldermann F, Bastert G, Strittmatter HJ. Schneeweiss A, et al. Among authors: sinn hp. Anticancer Drugs. 2004 Feb;15(2):127-35. doi: 10.1097/00001813-200402000-00005. Anticancer Drugs. 2004. PMID: 15075668

9

Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast.

Aulmann S, Schnabel PA, Helmchen B, Dienemann H, Drings P, Otto HF, Sinn HP. Aulmann S, et al. Among authors: sinn hp. Virchows Arch. 2005 Mar;446(3):305-9. doi: 10.1007/s00428-004-1163-5. Epub 2005 Jan 25. Virchows Arch. 2005. PMID: 15668805

10

Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.

Schneeweiss A, Schuetz F, Rudlowski C, Hahn M, Lauschner I, Sinn HP, von Fournier D, Sohn C. Schneeweiss A, et al. Among authors: sinn hp. Anticancer Drugs. 2005 Oct;16(9):1023-8. doi: 10.1097/01.cad.0000176508.73090.fb. Anticancer Drugs. 2005. PMID: 16162980 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters